Watch Demo

Europe Market Report for Optical Coherence Tomography 2017 - MedCore

Europe Market Report for Optical Coherence Tomography 2017 - MedCore

  • Publish Date:November 2016

  • Number of Pages:90

  • Report ID:4406674

  • Format:PDF

  • Publisher:iData Research, Inc.

$ 5495

Summary

Description
General Report Contents
- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
- Market Drivers & Limiters for each chapter segment
- Competitive Analysis for each chapter segment
- Section on recent mergers & acquisitions


These hybrid devices—which combine OCT’s with devices such as fundus cameras, scanning laser ophthalmoscopes (SLO), or angiography devices—allow ophthalmologist to be more efficient with both their time and space in their practices. This increase in efficiency can lead directly to increased profits for ophthalmologists. The market for standalone OCT has been around for some time now and so new machines are being sold to replace older technology. Spectral domain equipment is frequently being positioned in the market as a replacement for older time-domain technology.


The unit sale growth of the OCT market is expected to continue; however, it will slow throughout the forecast as the initial growth of hybrid devices also slows. Once this initial growth has ended it should stabilize to a low growth rate correlated to natural growth in the number of ophthalmic practices as populations grow. In addition, the replacement market will be stimulated over the forecast period as early users of OCTs are expected to upgrade to more advanced models. Also, optometrists have begun to purchase standalone OCT equipment in Europe. This is most notable in Germany, where a market for OCTs in the lower end of the pricing range is opening up in the optometry space.


In an effort to cater to the precise workflow requirements in ophthalmology and optometry settings, several of the largest OCT manufacturers have launched devices that combine OCT with another form of retinal imaging. The most common combination is OCT with fundus photography, although OCT has been combined with scanning laser ophthalmoscope equipment (SLO) as well. These devices offer the benefit of minimizing the space taken up by retinal imaging equipment and can contribute to workflow efficiency as the need to move patients around the practice is reduced.

Abstract
Optical coherence tomography (OCT) is a technique that allows physicians to acquire images of translucent or opaque material (such as biological tissue) at resolutions similar to low-power microscopes. The devices that make use of this technology to perform retinal imaging have become an integral part of tracking the progress of treatment and pathology for several important ocular diseases. The technique is often termed ‘optical ultrasound’ as imaging reflections within tissue are collected to provide cross-sectional images or topographic maps of the retinal surface. OCT is a non-invasive method of imaging the structure of the retina and provides physicians with information to detect ocular conditions such as macular holes, pre-retinal membranes, macular swelling or optic nerve damage. OCT devices are a particularly important diagnostic tool in the context of age-related macular degeneration (AMD).

Scope:2013-2023

Table of contents

TABLE OF CONTENTS I
LIST OF FIGURES IV
LIST OF CHARTS VI
EXECUTIVE SUMMARY 1
EUROPEAN MARKETS FOR DIAGNOSTIC AND INTERVENTIONAL OPHTHALMIC DEVICES 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 8
MARKET DEVELOPMENTS 12
MARKETS INCLUDED 13
KEY REPORT UPDATES 15
VERSION HISTORY 15
RESEARCH METHODOLOGY 16
1.1 RESEARCH SCOPE 16
1.2 IDATA'S 9-STEP METHODOLOGY 16
Step 1: Project Initiation & Team Selection 16
Step 2: Prepare Data Systems and Perform Secondary Research 18
Step 3: Preparation for Interviews & Questionnaire Design 19
Step 4: Performing Primary Research 19
Step 5: Research Analysis: Establishing Baseline Estimates 21
Step 6: Market Forecast and Analysis 22
Step 7: Identify Strategic Opportunities 23
Step 8: Final Review and Market Release 24
Step 9: Customer Feedback and Market Monitoring 25
COUNTRY PROFILES 26
2.1 INTRODUCTION 26
2.1.1 Population 26
2.1.2 GDP Per Capita 26
2.1.3 Price Index 26
2.2 GERMANY 28
2.3 FRANCE 29
2.4 UNITED KINGDOM 30
2.5 ITALY 31
2.6 SPAIN 32
2.7 BENELUX REGION 33
2.8 SCANDINAVIA REGION 34
2.9 PORTUGAL 35
2.10 AUSTRIA 36
2.11 SWITZERLAND 37
DISEASE OVERVIEW 38
3.1 INTRODUCTION 38
3.1.1 Age Related Macular Degeneration (AMD or ARMD) 38
3.1.2 Cataracts 41
3.1.3 Glaucoma 42
3.1.4 Diabetic Retinopathy 44
3.1.5 Retinal Detachment 46
3.1.6 Refractive Error 48
OPTICAL COHERENCE TOMOGRAPHY MARKET 50
4.1 INTRODUCTION 50
4.2 MARKET OVERVIEW 52
4.3 MARKET ANALYSIS AND FORECAST 56
4.3.1 Total Optical Coherence Tomography Market 56
4.3.2 Stand Alone Optical Coherence Tomography Market 63
4.3.3 Hybrid Optical Coherence Tomography Device Market 70
4.4 DRIVERS AND LIMITERS 77
4.4.1 Market Drivers 77
4.4.2 Market Limiters 78
4.5 COMPETITIVE ANALYSIS 79
ABBREVIATIONS 83



Chart List
Chart 1 1: Diagnostic and Interventional Ophthalmic Device Market by Segment, Europe, 2013 - 2023 3
Chart 1 2: Diagnostic and Interventional Ophthalmic Device Market Overview, Europe, 2013 & 2023 3
Chart 2 1: Country Profile, Germany, 2016 28
Chart 2 2: Country Profile, France, 2016 29
Chart 2 3: Country Profile, United Kingdom, 2016 30
Chart 2 4: Country Profile, Italy, 2016 31
Chart 2 5: Country Profile, Spain, 2016 32
Chart 2 6: Country Profile, Benelux Region, 2013 33
Chart 2 7: Country Profile, Scandinavia Region, 2013 34
Chart 2 8: Country Profile, Portugal, 2013 35
Chart 2 9: Country Profile, Austria, 2013 36
Chart 2 10: Country Profile, Switzerland, 2013 37
Chart 4 1: Optical Coherence Tomography Market by Segment, Europe, 2013 - 2023 54
Chart 4 2: Optical Coherence Tomography Market Breakdown, Europe, 2016 55
Chart 4 3: Optical Coherence Tomography Market Breakdown, Europe, 2023 55
Chart 4 4: Total Optical Coherence Tomography Market, Europe, 2013 - 2023 57
Chart 4 5: Stand Alone OCT Market, Europe, 2013 - 2023 64
Chart 4 6: Hybrid OCT Device Market, Europe, 2013 - 2023 71
Chart 4 7: Leading Competitors, Optical Coherence Tomography Market, Europe, 2016 82



Figure List
Figure 1 1: Diagnostic and Interventional Ophthalmic Device Competitor Market Share Ranking by Segment, Europe, 2016 (1 of 3) 5
Figure 1 2: Diagnostic and Interventional Ophthalmic Device Competitor Market Share Ranking by Segment, Europe, 2016 (2 of 3) 5
Figure 1 3: Diagnostic and Interventional Ophthalmic Device Competitor Market Share Ranking by Segment, Europe, 2016 (3 of 3) 6
Figure 1 4: Companies Researched in this Report, Europe, 2016 7
Figure 1 5: Factors Impacting the Diagnostic and Interventional Ophthalmic Device Market by Segment, Europe (1 of 4) 8
Figure 1 6: Factors Impacting the Diagnostic and Interventional Ophthalmic Device Market by Segment, Europe (2 of 4) 9
Figure 1 7: Factors Impacting the Diagnostic and Interventional Ophthalmic Device Market by Segment, Europe (3 of 4) 10
Figure 1 8: Factors Impacting the Diagnostic and Interventional Ophthalmic Device Market by Segment, Europe (4 of 4) 11
Figure 1 9: Recent Events in the Diagnostic and Interventional Ophthalmic Device Market, Europe, 2014 - 2016 12
Figure 1 10: Diagnostic and Interventional Ophthalmic Device Markets Covered, Europe, 2016 (1 of 2) 13
Figure 1 11: Diagnostic and Interventional Ophthalmic Device Markets Covered, Europe, 2016 (2 of 2) 14
Figure 1 12: Key Report Updates 15
Figure 1 13: Version History 15
Figure 3 1: Disease Rates by Country, Age Related Macular Degeneration, 2016 (1 of 2) 40
Figure 3 2: Disease Rates by Country, Age Related Macular Degeneration, 2016 (2 of 2) 40
Figure 3 3: Disease Rates by Country, Cataracts, 2016 (1 of 2) 41
Figure 3 4: Disease Rates by Country, Cataracts, 2016 (2 of 2) 41
Figure 3 5: Disease Rates by Country, Glaucoma, 2016 (1 of 2) 43
Figure 3 6: Disease Rates by Country, Glaucoma, 2016 (2 of 2) 43
Figure 3 7: Disease Rates by Country, Diabetic Retinopathy, 2016 (1 of 2) 45
Figure 3 8: Disease Rates by Country, Diabetic Retinopathy, 2016 (2 of 2) 45
Figure 3 9: Disease Rates by Country, Retinal Detachment, 2016 (1 of 2) 47
Figure 3 10: Disease Rates by Country, Retinal Detachment, 2016 (2 of 2) 47
Figure 3 11: Disease Rates by Country, Refractive Error, 2016 (1 of 2) 49
Figure 3 12: Disease Rates by Country, Refractive Error, 2016 (2 of 2) 49
Figure 4 1: Optical Coherence Tomography Market by Segment, Europe, 2013 - 2023 (€M) 53
Figure 4 2: Optical Coherence Tomography Market by Segment, Europe, 2013 - 2023 (US$M) 53
Figure 4 3: Total Optical Coherence Tomography Market, Europe, 2013 - 2023 (€ and US$) 57
Figure 4 4: Units Sold by Country, Total Optical Coherence Tomography Market, Europe, 2013 - 2023 58
Figure 4 5: ASP by Country, Total Optical Coherence Tomography Market, Europe, 2013 - 2023 (€) 59
Figure 4 6: ASP by Country, Total Optical Coherence Tomography Market, Europe, 2013 - 2023 (US$) 60
Figure 4 7: Total Optical Coherence Tomography Market by Country, Europe, 2013 - 2023 (€M) 61
Figure 4 8: Total Optical Coherence Tomography Market by Country, Europe, 2013 - 2023 (US$M) 62
Figure 4 9: Stand Alone OCT Market, Europe, 2013 - 2023 (€ and US$) 63
Figure 4 10: Units Sold by Country, Stand Alone OCT Market, Europe, 2013 - 2023 65
Figure 4 11: ASP by Country, Stand Alone OCT Market, Europe, 2013 - 2023 (€) 66
Figure 4 12: Stand Alone OCT ASP by Country, Europe, 2013 - 2023 (US$) 67
Figure 4 13: Stand Alone OCT Market by Country, Europe, 2013 - 2023 (€M) 68
Figure 4 14: Stand Alone OCT Market by Country, Europe, 2013 - 2023 (US$M) 69
Figure 4 15: Hybrid OCT Device Market, Europe, 2013 - 2023 (€ and US$) 70
Figure 4 16: Units Sold by Country, Hybrid OCT Device Market, Europe, 2013 - 2023 72
Figure 4 17: ASP by Country, Hybrid OCT Device Market, Europe, 2013 - 2023 (€) 73
Figure 4 18: ASP by Country, Hybrid OCT Device Market, Europe, 2013 - 2023 (US$) 74
Figure 4 19: Hybrid OCT Device Market by Country, Europe, 2013 - 2023 (€M) 75
Figure 4 20: Hybrid OCT Device Market by Country, Europe, 2013 - 2023 (US$M) 76
Figure 4 21: Drivers and Limiters, Optical Coherence Tomography Market, Europe, 2016 78
Figure 4 22: Leading Competitors, Optical Coherence Tomography Market, Europe, 2016 81


Companies
Alcon
AMO
Carl Zeiss Meditec
Bausch & Lomb
STAAR Surgical
Topcon
Haag-Streit
Oculus
Heidelberg Engineering
CSO
Nidek
Hoya
Bon Optic
Ziemer
Optovue
PhysIOL
Oertli
Quantel
Canon
Sonomed
CenterVue
Kowa
Accutome
Reichert
Tomey
Keeler
iCare

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.